EUVIMEDEUVIMED entdecken
Crossref

Oncological Outcomes of Transoral Laser Microsurgery for Early Stage Glottic Cancer with Involvement of the Anterior Commissure

Di Wang, Yan Liu, Lianji Wen, Shuang Li, Shuna Zhu, Tuanjie Wang, Dan Yu

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Di Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Glottis, Microsurgery, Laser Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the value of carbon dioxide transoral laser microsurgery (CO 2 TOLMS) for early‐stage glottic cancer with special regard to involvement of the anterior commissure (AC). Study Design Single‐center retrospective cohort study.

Setting

Grade‐A tertiary hospital.

Methods

A retrospective analysis of patients with early‐stage (Tis‐T2) glottic cancer who underwent CO 2 TOLMS. All patients had at least 2 years of follow‐up. The univariate and multivariate survival analyses were used to identify the risk factors for recurrence and the Kaplan‐Meier method was used to analyze OS and DSS rates.

Results

A total of 102 patients were included in the study. Eleven patients (10.78%) had recurrence. The univariate analysis showed that the recurrence was associated with the AC classification, T staging, tumor size, and tobacco use ( P < .05). However, on multivariate analysis, the AC classification was the only independent risk factor for recurrence ( P < .001, HR = 3.179). AC classification were distributed as follows: 59 (57.84%) AC0, 29 (28.43%) AC1, 8 (7.84%) AC2, and 6 (5.88%) AC3, 2‐year/5‐year OS and DSS rates were progressively reduced in the AC0, AC1, AC2, and AC3 groups ( P < .001). At the same T staging, the OS rates incrementally decreased as the level of involvement of the AC became higher ( P = .004).

Conclusion

CO 2 TOLMS is an effective treatment for early‐stage glottic cancer. AC involvement is an independent risk factors for recurrence and poor prognosis. The AC classification system may be better at grading the prognosis of patients with early‐stage glottic cancer and has prognostic value independent of T staging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsGlottisMicrosurgeryLaser TherapyNeoplasm StagingHumansMaleRetrospective StudiesFemaleMiddle AgedAgedTreatment OutcomeNeoplasm Recurrence, LocalAdultLasers, GasAged, 80 and over

Stichwörter der Autor:innen

CO2 TOLMSanterior commissurelaryngeal canceroncologic outcomesrecurrence

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.

Zitieren

APA

Wang, D., Liu, Y., Wen, L., Li, S., Zhu, S., Wang, T., & Yu, D. (2024). Oncological Outcomes of Transoral Laser Microsurgery for Early Stage Glottic Cancer with Involvement of the Anterior Commissure. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.767

Vancouver

Wang D, Liu Y, Wen L, Li S, Zhu S, Wang T, et al. Oncological Outcomes of Transoral Laser Microsurgery for Early Stage Glottic Cancer with Involvement of the Anterior Commissure. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.767

BibTeX
@article{Wang2024,
  author = {Wang, Di and Liu, Yan and Wen, Lianji and Li, Shuang and Zhu, Shuna and Wang, Tuanjie and Yu, Dan},
  title = {Oncological Outcomes of Transoral Laser Microsurgery for Early Stage Glottic Cancer with Involvement of the Anterior Commissure},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.767}
}
Kostenlos starten →